Zhejiang Haichang Biotech Co., Ltd.
Zhejiang Haichang Biotech Co., Ltd.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of WGI-0301 Plus Lenvatinib in Patients With Advanced HCC | Advanced Hepatocellular Carcinoma (HCC) | Not yet recruiting | Phase 1 / Phase 2 | 2026-09-15 | NCT07540832 | |
| Phase 2 Study of WGI-0301 for Advanced HCC | Advanced Hepatocellular Carcinoma (HCC) | Recruiting | Phase 2 | 2026-09-11 | NCT06309485 | |
| Phase 2 Study of WGI-0301 Plus Nivolumab in Patients With HCC and RCC | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoma, epithelial neoplasm, kidney cancer, kidney disorder, neoplasm, renal cell carcinoma, urinary system disorder | Not yet recruiting | Phase 2 | 2026-03-27 | NCT07494435 |